Brii Biosciences Ltd
HKEX:2137
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Brii Biosciences Ltd
HKEX:2137
|
CN |
Income Statement
Earnings Waterfall
Brii Biosciences Ltd
Income Statement
Brii Biosciences Ltd
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
0
|
1
|
2
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
52
N/A
|
52
+1%
|
1
-99%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(4 209)
|
(1 591)
|
(560)
|
(465)
|
(538)
|
(484)
|
(382)
|
(339)
|
|
| Selling, General & Administrative |
(208)
|
(251)
|
(195)
|
(189)
|
(198)
|
(205)
|
(204)
|
(151)
|
|
| Research & Development |
(492)
|
(593)
|
(438)
|
(381)
|
(401)
|
(326)
|
(249)
|
(241)
|
|
| Depreciation & Amortization |
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
0
|
(0)
|
0
|
|
| Other Operating Expenses |
(3 506)
|
(744)
|
76
|
108
|
63
|
48
|
71
|
52
|
|
| Operating Income |
(4 209)
N/A
|
(1 591)
+62%
|
(508)
+68%
|
(413)
+19%
|
(537)
-30%
|
(484)
+10%
|
(382)
+21%
|
(339)
+11%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
50
|
(2)
|
19
|
98
|
227
|
81
|
(40)
|
53
|
|
| Non-Reccuring Items |
(32)
|
(10)
|
0
|
(5)
|
126
|
132
|
(90)
|
(91)
|
|
| Pre-Tax Income |
(4 191)
N/A
|
(1 603)
+62%
|
(490)
+69%
|
(321)
+34%
|
(184)
+43%
|
(271)
-47%
|
(512)
-89%
|
(378)
+26%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4 191)
|
(1 603)
|
(490)
|
(321)
|
(184)
|
(271)
|
(512)
|
(378)
|
|
| Income to Minority Interest |
27
|
45
|
5
|
(6)
|
10
|
5
|
4
|
2
|
|
| Net Income (Common) |
(4 164)
N/A
|
(1 558)
+63%
|
(484)
+69%
|
(327)
+33%
|
(175)
+46%
|
(265)
-52%
|
(508)
-91%
|
(376)
+26%
|
|
| EPS (Diluted) |
-9.48
N/A
|
-2.15
+77%
|
-0.67
+69%
|
-0.45
+33%
|
-0.24
+47%
|
-0.36
-50%
|
-0.7
-94%
|
-0.52
+26%
|
|